Reunion Neuroscience (NASDAQ:REUN – Get Rating) and aTyr Pharma (NASDAQ:LIFE – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, earnings, valuation, dividends, profitability, risk and analyst recommendations. Analyst Ratings This is a breakdown of current ratings […]
Reunion Neuroscience (NASDAQ:REUN – Get Rating) and aTyr Pharma (NASDAQ:LIFE – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, institutional ownership, valuation, risk, analyst recommendations, earnings and dividends. Analyst Recommendations This is a breakdown of recent recommendations […]
/PRNewswire/ Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws.
Avidity Partners Management LP lessened its holdings in Reunion Neuroscience Inc. (NASDAQ:REUN – Get Rating) by 5.9% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 560,300 shares of the company’s stock after selling 34,900 shares during the quarter. Avidity Partners Management LP […]